PURPOSE: Evidence shows acanthosis nigricans is often associated with hyperinsulinemia and may indicate increased risk of type 2 diabetes mellitus. The purpose of this study was to determine the association of acanthosis nigricans with type 2 diabetes risk factors and disease in young persons. METHODS: We conducted a cross-sectional study in the Research in Outpatient Settings Network, a practice-based research network in southwestern US communities. Participating clinicians (N = 96) collected data on children and young adults aged 7 to 39 years seen during a 2-week sampling period. The main outcomes were the prevalence of acanthosis nigricans, type 2 diabetes risk factors (ethnicity, family history of type 2 diabetes, hypertension, overweight/obesity), type 2 diabetes, and the relationships among these. RESULTS: Among 1,133 patients sampled, risk factors for type 2 diabetes were common: 69% had a family history of the disease; 3% of children (aged 7 to 19 years) and 12% of adults had hypertension; 43% of children and 73% of adults were overweight or obese; and 80% were members of ethnic minorities. Acanthosis nigricans was found in 17% of children and 21% of adults. Among children and adults alike, the more type 2 diabetes risk factors that were present, the higher the prevalence of acanthosis nigricans (P <.001). The prevalence ratio for type 2 diabetes in patients with acanthosis nigricans was 1.97 (95% confidence interval, 1.18-3.27; P = .01) after controlling for age, body mass index, and the number of type 2 diabetes risk factors. Clinicians reported that the identification of acanthosis nigricans frequently led to discussions about lifestyle modification for decreasing the risk of type 2 diabetes. CONCLUSIONS: Patients with acanthosis nigricans are likely to have multiple risk factors for type 2 diabetes. Acanthosis nigricans may be an independent risk factor for this disease. Detection of acanthosis nigricans may help clinicians more rapidly identify high-risk individuals for diabetes counseling.
PURPOSE: Evidence shows acanthosis nigricans is often associated with hyperinsulinemia and may indicate increased risk of type 2 diabetes mellitus. The purpose of this study was to determine the association of acanthosis nigricans with type 2 diabetes risk factors and disease in young persons. METHODS: We conducted a cross-sectional study in the Research in Outpatient Settings Network, a practice-based research network in southwestern US communities. Participating clinicians (N = 96) collected data on children and young adults aged 7 to 39 years seen during a 2-week sampling period. The main outcomes were the prevalence of acanthosis nigricans, type 2 diabetes risk factors (ethnicity, family history of type 2 diabetes, hypertension, overweight/obesity), type 2 diabetes, and the relationships among these. RESULTS: Among 1,133 patients sampled, risk factors for type 2 diabetes were common: 69% had a family history of the disease; 3% of children (aged 7 to 19 years) and 12% of adults had hypertension; 43% of children and 73% of adults were overweight or obese; and 80% were members of ethnic minorities. Acanthosis nigricans was found in 17% of children and 21% of adults. Among children and adults alike, the more type 2 diabetes risk factors that were present, the higher the prevalence of acanthosis nigricans (P <.001). The prevalence ratio for type 2 diabetes in patients with acanthosis nigricans was 1.97 (95% confidence interval, 1.18-3.27; P = .01) after controlling for age, body mass index, and the number of type 2 diabetes risk factors. Clinicians reported that the identification of acanthosis nigricans frequently led to discussions about lifestyle modification for decreasing the risk of type 2 diabetes. CONCLUSIONS:Patients with acanthosis nigricans are likely to have multiple risk factors for type 2 diabetes. Acanthosis nigricans may be an independent risk factor for this disease. Detection of acanthosis nigricans may help clinicians more rapidly identify high-risk individuals for diabetes counseling.
Authors: Kimberly S H Yarnall; Kathryn I Pollak; Truls Østbye; Katrina M Krause; J Lloyd Michener Journal: Am J Public Health Date: 2003-04 Impact factor: 9.308
Authors: Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella Journal: JAMA Date: 2003-05-14 Impact factor: 56.272
Authors: Hassan A Kobaissi; Marc J Weigensberg; Geoff D C Ball; Martha L Cruz; Gabriel Q Shaibi; Michael I Goran Journal: Diabetes Care Date: 2004-06 Impact factor: 19.112
Authors: Kimberly Campbell-Voytal; Jeanette M Daly; Zsolt J Nagykaldi; Cheryl B Aspy; Rowena J Dolor; Lyle J Fagnan; Barcey T Levy; Hannah L Palac; LeAnn Michaels; V Beth Patterson; Miria Kano; Paul D Smith; Andrew L Sussman; Robert Williams; Pamela Sterling; Maeve O'Beirne; Anne Victoria Neale Journal: Clin Transl Sci Date: 2015-11-25 Impact factor: 4.689
Authors: Tamara S Hannon; Tamara M Dugan; Chandan K Saha; Steven J McKee; Stephen M Downs; Aaron E Carroll Journal: JAMA Pediatr Date: 2017-04-01 Impact factor: 16.193
Authors: Alberta S Kong; Robert L Williams; Robert Rhyne; Virginia Urias-Sandoval; Gina Cardinali; Nancy F Weller; Betty Skipper; Robert Volk; Elvan Daniels; Bennett Parnes; Laurie McPherson Journal: J Am Board Fam Med Date: 2010 Jul-Aug Impact factor: 2.657
Authors: John Robert Brandt; Aaron Jacobs; Hengameh H Raissy; Franceska Marie Kelly; Amy Otten Staples; Ellen Kaufman; Craig Stephen Wong Journal: Pediatr Nephrol Date: 2010-02-18 Impact factor: 3.714
Authors: Alberta S Kong; Laura Vanderbloemen; Betty Skipper; John Leggott; Emilie Sebesta; Robert Glew; Mark R Burge Journal: J Pediatr Endocrinol Metab Date: 2012 Impact factor: 1.634
Authors: Robert L Williams; Laurie McPherson; Alberta Kong; Betty Skipper; Nancy Weller Journal: J Am Board Fam Med Date: 2009 Jul-Aug Impact factor: 2.657